21.95 USD
0 (0%)
21.95 USD
0 (0%)
TBRG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. There are concerns on the financial health of TBRG while its profitability can be described as average. TBRG scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
- In the past year TBRG was profitable.
- In the past year TBRG had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: TBRG reported negative net income in multiple years.
- TBRG had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- With a decent Return On Assets value of 1.36%, TBRG is doing good in the industry, outperforming 80.00% of the companies in the same industry.
- With a decent Return On Equity value of 3.01%, TBRG is doing good in the industry, outperforming 80.00% of the companies in the same industry.
- The Return On Invested Capital of TBRG (5.72%) is better than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.36% | ||
| ROE | 3.01% | ||
| ROIC | 5.72% |
ROA(3y)-3.89%
ROA(5y)-0.55%
ROE(3y)-9.64%
ROE(5y)-2.79%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 1.55%, TBRG is in the better half of the industry, outperforming 77.14% of the companies in the same industry.
- The Operating Margin of TBRG (7.15%) is better than 77.14% of its industry peers.
- TBRG's Operating Margin has declined in the last couple of years.
- Looking at the Gross Margin, with a value of 53.16%, TBRG is doing worse than 62.86% of the companies in the same industry.
- In the last couple of years the Gross Margin of TBRG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.15% | ||
| PM (TTM) | 1.55% | ||
| GM | 53.16% |
OM growth 3Y-40.35%
OM growth 5Y-26.39%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.4%
GM growth 5Y-0.64%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TBRG is destroying value.
- TBRG has more shares outstanding than it did 1 year ago.
- TBRG has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, TBRG has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 2.11 indicates that TBRG is not a great score, but indicates only limited risk for bankruptcy at the moment.
- TBRG has a Altman-Z score (2.11) which is comparable to the rest of the industry.
- TBRG has a debt to FCF ratio of 7.86. This is a slightly negative value and a sign of low solvency as TBRG would need 7.86 years to pay back of all of its debts.
- TBRG has a Debt to FCF ratio (7.86) which is comparable to the rest of the industry.
- TBRG has a Debt/Equity ratio of 0.89. This is a neutral value indicating TBRG is somewhat dependend on debt financing.
- TBRG's Debt to Equity ratio of 0.89 is on the low side compared to the rest of the industry. TBRG is outperformed by 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.89 | ||
| Debt/FCF | 7.86 | ||
| Altman-Z | 2.11 |
ROIC/WACC0.56
WACC10.23%
2.3 Liquidity
- A Current Ratio of 1.91 indicates that TBRG should not have too much problems paying its short term obligations.
- The Current ratio of TBRG (1.91) is comparable to the rest of the industry.
- A Quick Ratio of 1.90 indicates that TBRG should not have too much problems paying its short term obligations.
- TBRG's Quick ratio of 1.90 is in line compared to the rest of the industry. TBRG outperforms 42.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.9 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 266.00% over the past year.
- The earnings per share for TBRG have been decreasing by -40.46% on average. This is quite bad
- TBRG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.88%.
- TBRG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.53% yearly.
EPS 1Y (TTM)266%
EPS 3Y-58.61%
EPS 5Y-40.46%
EPS Q2Q%519.05%
Revenue 1Y (TTM)-16.88%
Revenue growth 3Y6.89%
Revenue growth 5Y4.53%
Sales Q2Q%2.72%
3.2 Future
- Based on estimates for the next years, TBRG will show a very strong growth in Earnings Per Share. The EPS will grow by 134.53% on average per year.
- TBRG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.67% yearly.
EPS Next Y1149.5%
EPS Next 2Y229.6%
EPS Next 3Y134.53%
EPS Next 5YN/A
Revenue Next Year3.21%
Revenue Next 2Y3.62%
Revenue Next 3Y3.67%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 11.99 indicates a reasonable valuation of TBRG.
- TBRG's Price/Earnings ratio is rather cheap when compared to the industry. TBRG is cheaper than 94.29% of the companies in the same industry.
- TBRG is valuated cheaply when we compare the Price/Earnings ratio to 27.33, which is the current average of the S&P500 Index.
- Based on the Price/Forward Earnings ratio of 10.63, the valuation of TBRG can be described as reasonable.
- Based on the Price/Forward Earnings ratio, TBRG is valued cheaply inside the industry as 91.43% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.12, TBRG is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.99 | ||
| Fwd PE | 10.63 |
4.2 Price Multiples
- 85.71% of the companies in the same industry are more expensive than TBRG, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, TBRG is valued cheaply inside the industry as 88.57% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.77 | ||
| EV/EBITDA | 9.2 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- TBRG's earnings are expected to grow with 134.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y229.6%
EPS Next 3Y134.53%
5. Dividend
5.1 Amount
- No dividends for TBRG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
21.95
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)03-09 2026-03-09/amc
Inst Owners70.3%
Inst Owner Change0%
Ins Owners3.34%
Ins Owner Change6.51%
Market Cap329.47M
Revenue(TTM)349.88M
Net Income(TTM)5.42M
Analysts76.36
Price Target23.05 (5.01%)
Short Float %5.47%
Short Ratio7.51
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)103.24%
Min EPS beat(2)83.56%
Max EPS beat(2)122.91%
EPS beat(4)3
Avg EPS beat(4)34.96%
Min EPS beat(4)-87.3%
Max EPS beat(4)122.91%
EPS beat(8)5
Avg EPS beat(8)-2.39%
EPS beat(12)7
Avg EPS beat(12)-5.28%
EPS beat(16)9
Avg EPS beat(16)-3.09%
Revenue beat(2)0
Avg Revenue beat(2)-2.17%
Min Revenue beat(2)-3.3%
Max Revenue beat(2)-1.05%
Revenue beat(4)1
Avg Revenue beat(4)-0.92%
Min Revenue beat(4)-3.3%
Max Revenue beat(4)1.51%
Revenue beat(8)2
Avg Revenue beat(8)-0.82%
Revenue beat(12)2
Avg Revenue beat(12)-1.3%
Revenue beat(16)5
Avg Revenue beat(16)-0.47%
PT rev (1m)0%
PT rev (3m)-8.69%
EPS NQ rev (1m)-0.33%
EPS NQ rev (3m)-2.77%
EPS NY rev (1m)0%
EPS NY rev (3m)17.11%
Revenue NQ rev (1m)-0.16%
Revenue NQ rev (3m)-1.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.99 | ||
| Fwd PE | 10.63 | ||
| P/S | 0.94 | ||
| P/FCF | 15.77 | ||
| P/OCF | 8.58 | ||
| P/B | 1.83 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.2 |
EPS(TTM)1.83
EY8.34%
EPS(NY)2.06
Fwd EY9.4%
FCF(TTM)1.39
FCFY6.34%
OCF(TTM)2.56
OCFY11.66%
SpS23.31
BVpS12.02
TBVpS-6.93
PEG (NY)0.01
PEG (5Y)N/A
Graham Number22.24
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.36% | ||
| ROE | 3.01% | ||
| ROCE | 7.24% | ||
| ROIC | 5.72% | ||
| ROICexc | 6.07% | ||
| ROICexgc | 47.77% | ||
| OM | 7.15% | ||
| PM (TTM) | 1.55% | ||
| GM | 53.16% | ||
| FCFM | 5.97% |
ROA(3y)-3.89%
ROA(5y)-0.55%
ROE(3y)-9.64%
ROE(5y)-2.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-34.77%
ROICexgc growth 5Y-16.72%
ROICexc growth 3Y-36.47%
ROICexc growth 5Y-24.96%
OM growth 3Y-40.35%
OM growth 5Y-26.39%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.4%
GM growth 5Y-0.64%
F-Score8
Asset Turnover0.88
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.89 | ||
| Debt/FCF | 7.86 | ||
| Debt/EBITDA | 3.13 | ||
| Cap/Depr | 66.1% | ||
| Cap/Sales | 5% | ||
| Interest Coverage | 1.87 | ||
| Cash Conversion | 74.56% | ||
| Profit Quality | 385.36% | ||
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.9 | ||
| Altman-Z | 2.11 |
F-Score8
WACC10.23%
ROIC/WACC0.56
Cap/Depr(3y)79.13%
Cap/Depr(5y)69.66%
Cap/Sales(3y)6.13%
Cap/Sales(5y)4.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)266%
EPS 3Y-58.61%
EPS 5Y-40.46%
EPS Q2Q%519.05%
EPS Next Y1149.5%
EPS Next 2Y229.6%
EPS Next 3Y134.53%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.88%
Revenue growth 3Y6.89%
Revenue growth 5Y4.53%
Sales Q2Q%2.72%
Revenue Next Year3.21%
Revenue Next 2Y3.62%
Revenue Next 3Y3.67%
Revenue Next 5YN/A
EBIT growth 1Y432.85%
EBIT growth 3Y-36.24%
EBIT growth 5Y-23.05%
EBIT Next Year161.45%
EBIT Next 3Y48.17%
EBIT Next 5YN/A
FCF growth 1Y380.13%
FCF growth 3Y-29.73%
FCF growth 5Y-20.85%
OCF growth 1Y147.92%
OCF growth 3Y-12.4%
OCF growth 5Y-5.94%
TRUBRIDGE INC / TBRG FAQ
What is the ChartMill fundamental rating of TRUBRIDGE INC (TBRG) stock?
ChartMill assigns a fundamental rating of 4 / 10 to TBRG.
What is the valuation status for TBRG stock?
ChartMill assigns a valuation rating of 9 / 10 to TRUBRIDGE INC (TBRG). This can be considered as Undervalued.
Can you provide the profitability details for TRUBRIDGE INC?
TRUBRIDGE INC (TBRG) has a profitability rating of 4 / 10.
What is the financial health of TRUBRIDGE INC (TBRG) stock?
The financial health rating of TRUBRIDGE INC (TBRG) is 3 / 10.
Is the dividend of TRUBRIDGE INC sustainable?
The dividend rating of TRUBRIDGE INC (TBRG) is 0 / 10 and the dividend payout ratio is 0%.